BusinessZafgen Presents New Data from the Phase 3 bestPWS Study Evaluating Beloranib in Prader-Willi Syndrome at ENDO 2016By Nasdaq OMXApr 3, 2016, 5:15 PM UTC
BusinessCHMP Issues Positive Opinion Recommending DARZALEX(r) (daratumumab) for Relapsed and Refractory Multiple MyelomaBy Nasdaq OMXApr 1, 2016, 3:46 PM UTC
BusinessnTIDE Jobs Report: Steady Job Numbers May Signal Start of Turnaround for People With DisabilitiesBy Nasdaq OMXApr 1, 2016, 2:48 PM UTC
Business15th Annual Sexual Assault Awareness Month Prioritizes Prevention, Promotes Understanding of Sexual Assault as a Public Health IssueBy Nasdaq OMXMar 31, 2016, 6:18 PM UTC
BusinessProsthodontists' Infographic Offers 6 Pearls of Wisdom to Care for Restored Pearly WhitesBy Nasdaq OMXMar 31, 2016, 6:04 PM UTC
BusinessProsthodontists' Infographic Offers 6 Pears of Wisdom to Care for Restored Pearly WhitesBy Nasdaq OMXMar 31, 2016, 5:07 PM UTC
BusinessSkilled geriatrician Heidi J. Syropoulos, M.D., joins Independence Blue Cross as medical director of Government MarketsBy Nasdaq OMXMar 31, 2016, 3:00 PM UTC
BusinessSandoz Canada Inc. launches PrTOBRAMYCIN INHALATION SOLUTION, a generic version of PrTOBI indicated for pulmonary infections in cystic fibrosis patientsBy Nasdaq OMXMar 31, 2016, 1:20 PM UTC
